search_icon 

close_icon

search_icon  

search_icon  

CV Dr. Janine Kimpel

Name: Janine Kimpel
Date of birth: November 5, 1982
Institute of Virology
Innsbruck Medical University
Peter-Mayr-Straße 4b
6020 Innsbruck, Austria
Telephone:
0043-512-9003-71725
Fax:
0043-512-9003-73701
E-Mail:
Janine.Kimpel@i-med.ac.at

Education

1988-2001 School, Germany
2001 Abitur, Grimmelshausen Gymnasium, Gelnhausen, Germany
2001-2006 Studies of Biology, Johann-Wolfgang-Goethe University Frankfurt, Germany

2005-2006
Diploma thesis in Biology at the “Institute for Biomedical Research Georg-Speyer-Haus”, Frankfurt am Main, Germany: “Untersuchungen zur in vivo Produktion eines rekombinanten Antikörpers durch Leukozyten im Mausmodell”

10/2006- 03/2010 PhD thesis in Biology “Analyse der Wirksamkeit einer Gentherapie der HIV-Infektion im humanisierten Mausmodell”, Supervisor: Prof. Dr. Dorothee von Laer
2010 Dr. phil. nat.

Scientific Career

10/2006- 09/2009
Scholarship graduate school 1172, Erforschung, Entwicklung und Sicherheit von biotechnologisch hergestellten Arzneimitteln- „Biologicals“

06/2009- 08/2009

Publications

89 publications in peer-reviewed journals, 6 book chapters, 2 patents

Research Interests

Virology, Vaccine development, Immunology, Regulation of the immune responses

Future research activities

The following main focus will be studied:Alternative approaches to develop vaccines

  • Development of a complement-based anti-retroviral therapy
  • Impact of complement on DCs infections
  • Impact of complement on the regulation of antigen presentation and CTL responses

Current funding

  • 6th framework of the EU (LSHP-CT-2005-018685; DEC-VAC): “Development of a Dendritic Cell-targeted Vaccine against AIDS” 174.00.-€
  • FWF Grant 17914: “Development of complement-based antiretroviral therapy in a mouse model” 340.000.-€
  • FFG Grant, Bridge-Project 815463: „Selbst-Transfizierende Antisense-Wirkstoffe als Therapie gegen HIV“ 200.000.-€
  • Prize Project: „Antiviraler Wirk- und Impfstoff“ 125.000.-€
  • Tiroler Zukunftsstiftung, TWF-2008-1-562: „Development of antiretroviral therapy based on C4b-binding protein” 44.000.-€

About

Publikationen